Published: Fri, April 21, 2017
Business | By Max Garcia

Is Acadia Healthcare Company, Inc. (ACHC) Sell Now?

The share price of the company (NASDAQ:ACHC) was down -0.28%, with a high of 42.96 during the day and the volume of Acadia Healthcare Company, Inc. shares traded was 1781997. The firm now has a $45.00 price target on the stock.

Several analysts have recently issued reports on ACHC shares.

14 number of analysts have estimated the sales of the company for the quarter ending April 25, 2017, analysts estimated mean sale target of 730.27 million while high and low sale targets are estimated at 751 million and 715.3 million respectively. Mizuho reaffirmed a "buy" rating and set a $52.00 target price (up previously from $45.00) on shares of Acadia Healthcare Company in a report on Monday, February 27th. Royal Bank of Canada reaffirmed a "buy" rating and set a $56.00 target price on shares of Acadia Healthcare Company in a report on Tuesday, January 3rd.

5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Acadia Healthcare Company, Inc. Acadia Healthcare Company earned a media sentiment score of 0.31 on AlphaOne's scale. They now have a United States dollars 52 price target on the stock. (NASDAQ:ACHC) dropped -0.12% to hit $42.73. However the price at the close of last session was 0.65% higher than its 50-day moving average and -2.57% under its 200-day moving average. The P/E ratio was recorded at 838.82.The volatility in the previous week has experienced by 2.43% and observed of 3.19% in the previous month.80.00% ownership is held by institutional investors while insiders hold ownership of 1.10%. Over the 52-week time span, the stock notched a high price of $65 and its minimum price was $32.54. News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company, Inc. with's FREE daily email newsletter.

12/20/2016 - Acadia Healthcare Company, Inc. had its "buy" rating reiterated by analysts at Jefferies. The business had revenue of $702.89 million for the quarter, compared to analyst estimates of $708.41 million. During the same period a year ago, the firm posted $0.59 earnings per share. Acadia Healthcare Company's revenue was up 41.9% on a year-over-year basis. The company maintains price to book ratio of 3.08 industry average at 0.33.

10/19/2016 - Acadia Healthcare Company, Inc. had its "buy" rating reiterated by analysts at UBS. If you are accessing this news story on another site, it was stolen and republished in violation of United States and global copyright and trademark legislation. During the past three month period the stock surged 12.49% and decreased -0.07% in past six month.

In other Acadia Healthcare Company news, VP Randall P. Goldberg sold 914 shares of Acadia Healthcare Company stock in a transaction that occurred on Wednesday, March 8th. The shares were sold at an average price of $34.58, for a total transaction of $968,240.00. MD now owns 10,958,149 shares of the company's stock valued at $542,976,000 after buying an additional 1,103,621 shares in the last quarter. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.

A number of large investors have recently modified their holdings of ACHC. Price T Rowe Associates Inc. Wells Fargo & Company MN raised its position in Acadia Healthcare Company by 30.0% in the third quarter. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued.

Zackspresents analysts with an ABR (Average Broker Rating), based on the sell-side recommendations.

The Company has 87.55 million shares outstanding and 84.64 million shares were floated in market.

Like this: